Lauren B Messinger1, Connie E Alford2, John M Csokmay3, Melinda B Henne4, Sunni L Mumford5, James H Segars6, Alicia Y Armstrong7. 1. Department of Obstetrics and Gynecology, St. Vincent Women's Hospital, Indianapolis, Indiana. Electronic address: lmessing@stvincent.org. 2. South Florida Institute for Reproductive Medicine, Naples, Florida. 3. Division of Reproductive Endocrinology, Department of Obstetrics and Gynecology, Walter Reed National Military Medical Center, Bethesda, Maryland. 4. Reproductive Medicine Associates of Texas, San Antonio, Texas. 5. Epidemiology Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland. 6. Reproductive Science and Women's Health Research, Department of Obstetrics and Gynecology, Johns Hopkins University, Baltimore, Maryland. 7. Program in Reproductive and Adult Endocrinology, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland.
Abstract
OBJECTIVE: To compare cost and efficacy of tubal anastomosis to in vitro fertilization (IVF) in women who desired fertility after a tubal ligation. DESIGN: Cost-effectiveness analysis. SETTING: Not applicable. PATIENT(S): Not applicable. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Cost per ongoing pregnancy. RESULT(S): Cost per ongoing pregnancy for women after tubal anastomosis ranged from $16,446 to $223,482 (2014 USD), whereas IVF ranged from $32,902 to $111,679 (2014 USD). Across maternal age groups <35 and 35-40, years tubal anastomosis was more cost effective than IVF for ongoing pregnancy. Sensitivity analyses validated these findings across a wide range of ongoing pregnancy probabilities as well as costs per procedure. CONCLUSION(S): Tubal anastomosis was the most cost-effective approach for most women less than 41 years of age, whereas IVF was the most cost-effective approach for women aged ≥41 years who desired fertility after tubal ligation. A model was created that can be modified based on cost and success rates in individual clinics for improved patient counseling.
OBJECTIVE: To compare cost and efficacy of tubal anastomosis to in vitro fertilization (IVF) in women who desired fertility after a tubal ligation. DESIGN: Cost-effectiveness analysis. SETTING: Not applicable. PATIENT(S): Not applicable. INTERVENTION(S): Not applicable. MAIN OUTCOME MEASURE(S): Cost per ongoing pregnancy. RESULT(S): Cost per ongoing pregnancy for women after tubal anastomosis ranged from $16,446 to $223,482 (2014 USD), whereas IVF ranged from $32,902 to $111,679 (2014 USD). Across maternal age groups <35 and 35-40, years tubal anastomosis was more cost effective than IVF for ongoing pregnancy. Sensitivity analyses validated these findings across a wide range of ongoing pregnancy probabilities as well as costs per procedure. CONCLUSION(S): Tubal anastomosis was the most cost-effective approach for most women less than 41 years of age, whereas IVF was the most cost-effective approach for women aged ≥41 years who desired fertility after tubal ligation. A model was created that can be modified based on cost and success rates in individual clinics for improved patient counseling.
Authors: Khadra A Jama-Alol; Alexandra P Bremner; Gavin Pereira; Louise M Stewart; Eva Malacova; Rachael Moorin; David B Preen Journal: BMC Womens Health Date: 2017-11-25 Impact factor: 2.809